PCN72 - Hormonal Receptor Positive, HER2 Negative Metastatic Breast Cancer (MBC HR+HER2-): Pre and Post-Progression Costs Under the Public Health Care System (SUS) and Societal Perspectives in Brazil
| Autor: | Haas, L.C., Fernandes, R.A., Bines, J., Caldas, A., Valentim, J. |
|---|---|
| Zdroj: | In Value in Health November 2013 16(7):A404-A404 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect